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This editorial is written in response to Roberts BA. 
Legalized Cannabis in Colorado Emergency Departments: 
A Cautionary Review of Negative Health and Safety 
Effects. West J Emerg Med. 2019;20(4):557-72. (https://
escholarship.org/uc/item/6xb8q31x)
Dr. Roberts has delivered an excellent review of many 
medical aspects of cannabis use and the effect of cannabis 
legalization on emergency medicine in Colorado.1 As 
emergency physician researchers in Colorado, we echo 
many of his concerns. As he notes, since legalization, we 
have identified an increase in accidental pediatric exposures 
(some of which resulted in severe effects)2-4, an increase 
in emergency department visits for hyperemesis (most 
likely related to cannabinoid hyperemesis),5 an increased 
number of visits attributable to cannabis edibles,6 a 
disproportionate increase in adult7 and adolescent8 mental 
health visits related to cannabis, and an increased number 
of visits for cannabis toxicity (greater in tourists than 
locals).9 These effects are measurable, and while the direct 
attribution of these changes to cannabis legalization are 
limited to observational data that is subject to temporal 
trends, selection bias, and confounding, we believe the 
links between these changes and cannabis legalization are 
plausible, consistent and relevant.  
While much of the focus in Colorado has been on 
recreational cannabis, it is important to note that many of 
the issues identified began before recreational cannabis 
was available in 2014. In Colorado, medical cannabis was 
legalized in 2000 and has been widely available since 
2009. In Colorado, the qualifying medical conditions for 
cannabis use include the following: cancer, glaucoma HIV, 
severe pain, seizures, nausea, muscle spasm, post-traumatic 
stress disorder (PTSD), autism spectrum disorder, and 
cachexia.10 As of June 2019, almost 84,000 patients have 
an active medical marijuana registration, 337 (0.4%) less 
than 18 years of age.11 As with any therapy, the adverse 
effects we have identified must be balanced against the 
potential benefits to patients and society. However, there 
are few high-quality evidenced based studies to support 
these recommendations. Without clinical trials the 
measurement of the positive effects of cannabis remain 
largely anecdotal. There are additional concerns for 
reported cannabinoid content and claims on treatment for 
disease. The United States Food and Drug Administration 
(FDA) has issued numerous warning letters to various 
cannabidiol manufacturers for false claims in relation to 
disease diagnosis and treatment.13 The medical utility of 
cannabis is further limited by insufficient training provided 
to medical professionals and trainees, in addition to the 
reliance of many users on non-medical providers to guide 
therapeutic choices. For example, many dispensaries will 
recommend cannabis to pregnant women despite various 
national guidelines cautioning against this practice.12 The 
medical benefits of cannabis should have been evaluated 
using accepted clinical standards prior to providing legal 
status as medical treatments. 
Recreational use has no demonstrated inherent health 
benefit. While some have suggested that it may increase 
relaxation and reduce stress, there are no clinical studies 
to support those claims. One plausible health benefit is 
the substitution of cannabis for other more dangerous 
recreational drugs; however, this is also not studied. 
Unfortunately, in Colorado we see that cannabis is also 
often combined with alcohol and other drugs and the 
relative increase in adverse effects may outweigh this 
potential benefit.  Despite the observed increase in cannabis 
related driving fatalities in Colorado, 55% of cannabis 
users believed it was safe to drive under the influence 
of cannabis.14 There have been mixed results on how 
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marijuana legalization has affected medical and nonmedical 
opioid use and prescribing.15-16 
The discussion around the impact of cannabis on 
the healthcare system is (as with many issues) not 
absolute. When we speak to cannabis supporters we often 
hear the justification that it is safer than alternatives, and 
there are no real adverse effects. We believe our work 
has clearly demonstrated that cannabis legalization has 
measurably impacted the delivery of emergency care in 
Colorado. However, it is important to put the magnitude 
of this impact in perspective. Since 2006, more than 2000 
Coloradans have died from opioid overdose, and tobacco 
use-associated healthcare costs in Colorado are almost 2 
billion dollars per year. While it is disingenuous to say that 
cannabis legalization has not impacted emergency medicine 
in Colorado, it is important to recognize that there are many 
greater threats to public health and to provide appropriate 
focus to each of these conditions. A legitimate discussion 
around the health effects of cannabis in Colorado requires 
a fair assessment of the risks and benefits by advocates and 
critics alike.  
Continued surveillance on both the positive and 
negative effects on marijuana legalization, and evidence-
based research is needed as more states continue to pass 
medical and recreational marijuana. The long-term effects 
of increased availability of high-THC-cannabis are still 
to be determined. It is critical for public health officials, 
healthcare providers and legislators, in conjunction with 
advocates and industry representatives, to work toward 
regulations aimed at minimizing the public health impact of 
cannabis legalization on society.  
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